UK approves Moderna’s Covid-19 vaccine for 12 to 17-year-olds
Spikevax vaccine, previously called Covid-19 Vaccine Moderna, was already approved in the UK, for active immunisation in adults…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
18 Aug 21
Spikevax vaccine, previously called Covid-19 Vaccine Moderna, was already approved in the UK, for active immunisation in adults…
17 Aug 21
Initial data was submitted from Phase 1 of the Phase 1/2/3 clinical trial programme, evaluating the third dose…
16 Aug 21
The company is working to optimise production of Welireg, which is an oral hypoxia-inducible factor-2 alpha (HIF-2α) inhibitor,…
16 Aug 21
The immunogenicity of Ticovac was assessed in clinical studies across the population aged between 1 to 15 years…
13 Aug 21
A focus on clinical trial supply chains, how new technology is making trials easier and the pressure of…
13 Aug 21
Durezol is a topical corticosteroid, indicated for inflammation and pain associated with ocular surgery, and for endogenous anterior…
13 Aug 21
The majority of people vaccinated with Moderna’s vaccine maintained both binding and functional antibodies against SARS-CoV-2 variants
12 Aug 21
The FDA approval is based on Phase 3 CLEAR/KEYNOTE-581 trial, in which Keytruda plus Lenvima combination was superior…
11 Aug 21
The MHRA approval allows the use of Epidyolex in England, Wales and Scotland, along with all 27 countries…
11 Aug 21
The new manufacturing facility will support Canada with direct access to domestically manufactured vaccines against respiratory viruses